TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs3824662
log Bayes Factor = 2.38261
Chromosome 10   position 8,104,208  (GRCh37) Explore rs3824662 on Ensembl!
Variant rs3824662 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.985 0.015 0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
0.985 0.015 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.985 0.015 0.000
C77.1 Intrathoracic lymph nodes
0.981 0.019 0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.970 0.030 0.000
C79 Secondary malignant neoplasm of other sites
0.948 0.052 0.000
C78.7 Secondary malignant neoplasm of liver
0.944 0.056 0.000
C78.2 Secondary malignant neoplasm of pleura
0.931 0.069 0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.924 0.076 0.000
C77.4 Inguinal and lower limb lymph nodes
0.894 0.106 0.000
C77.3 Axillary and upper limb lymph nodes
0.865 0.135 0.000
C77.5 Intrapelvic lymph nodes
0.860 0.140 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.858 0.142 0.000
C77.8 Lymph nodes of multiple regions
0.849 0.151 0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.785 0.215 0.000
C79.2 Secondary malignant neoplasm of skin
0.761 0.239 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.755 0.245 0.000
C77.2 Intra-abdominal lymph nodes
0.744 0.256 0.000
C78.4 Secondary malignant neoplasm of small intestine
0.728 0.272 0.000
C78.1 Secondary malignant neoplasm of mediastinum
0.715 0.285 0.000
C79.6 Secondary malignant neoplasm of ovary
0.712 0.288 0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.706 0.294 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.688 0.312 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.656 0.344 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.628 0.372 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.392 0.608
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.399 0.601
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.403 0.597
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.596 0.404 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.412 0.588
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.424 0.576
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.437 0.563
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.549 0.451 0.000
T43.2 Other and unspecified antidepressants
0.000 0.452 0.548
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.454 0.546
T40.2 Other opioids
0.000 0.455 0.545
T42.4 Benzodiazepines
0.000 0.457 0.543
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.459 0.541
C77.9 Lymph node, unspecified
0.513 0.487 0.000
T40.6 Other and unspecified narcotics
0.000 0.500 0.500
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.504 0.496
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.504 0.496
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.508 0.492
C78.0 Secondary malignant neoplasm of lung
0.491 0.509 0.000
C76.2 Abdomen
0.489 0.511 0.000
C76.1 Thorax
0.477 0.523 0.000
C76.8 Overlapping lesion of other and ill-defined sites
0.470 0.530 0.000
C76.7 Other ill-defined sites
0.470 0.530 0.000
C76.5 Lower limb
0.470 0.530 0.000
C76.4 Upper limb
0.470 0.530 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.550 0.450
C80 Malignant neoplasm without specification of site
0.449 0.551 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.447 0.553 0.000
T39.1 4-Aminophenol derivatives
0.000 0.559 0.441
T43.9 Psychotropic drug, unspecified
0.000 0.564 0.436
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.564 0.436
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.564 0.436
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.566 0.434
C76.0 Head, face and neck
0.433 0.567 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.569 0.431
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.569 0.431
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.569 0.431
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.569 0.431
C76.3 Pelvis
0.428 0.572 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.574 0.426
T43.6 Psychostimulants with abuse potential
0.000 0.577 0.423
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.578 0.422
T42.3 Barbiturates
0.000 0.578 0.422
T42.2 Succinimides and oxazolidinediones
0.000 0.578 0.422
T42.0 Hydantoin derivatives
0.000 0.578 0.422
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.585 0.415
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.587 0.413
T40.8 Lysergide [LSD]
0.000 0.587 0.413
T40.7 Cannabis (derivatives)
0.000 0.587 0.413
T40.5 Cocaine
0.000 0.587 0.413
T40.3 Methadone
0.000 0.587 0.413
T40.1 Heroin
0.000 0.587 0.413
T40.0 Opium
0.000 0.587 0.413
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.600 0.400
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.604 0.396
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.606 0.394
T42.1 Iminostilbenes
0.000 0.606 0.394
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.610 0.390
T39.4 Antirheumatics, not elsewhere classified
0.000 0.612 0.388
T39.2 Pyrazolone derivatives
0.000 0.612 0.388
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.617 0.383
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.618 0.382
T40.4 Other synthetic narcotics
0.000 0.625 0.375
T36 Poisoning by systemic antibiotics
0.000 0.631 0.369
C34 Malignant neoplasm of bronchus and lung
0.357 0.643 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.644 0.355
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.644 0.355
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.644 0.355
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.644 0.355
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.644 0.355
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.644 0.355
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.644 0.355
T44.0 Anticholinesterase agents
0.000 0.644 0.355
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.646 0.354
C34.9 Bronchus or lung, unspecified
0.349 0.651 0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.344 0.656 0.000
C67 Malignant neoplasm of bladder
0.342 0.658 0.000
Chapter II Neoplasms
0.340 0.660 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.660 0.340
C64-C68 Malignant neoplasms of urinary tract
0.337 0.663 0.000
C77.0 Lymph nodes of head, face and neck
0.331 0.669 0.000
C67.4 Posterior wall of bladder
0.328 0.672 0.000
C67.6 Ureteric orifice
0.328 0.672 0.000
C34.2 Middle lobe, bronchus or lung
0.322 0.678 0.000
C34.3 Lower lobe, bronchus or lung
0.320 0.680 0.000
T46.1 Calcium-channel blockers
0.000 0.683 0.317
T45.5 Anticoagulants
0.000 0.688 0.311
C34.0 Main bronchus
0.311 0.689 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.691 0.309
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.691 0.309
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.691 0.309
T47.7 Emetics
0.000 0.691 0.309
T47.6 Antidiarrhoeal drugs
0.000 0.691 0.309
T47.5 Digestants
0.000 0.691 0.309
T47.4 Other laxatives
0.000 0.691 0.309
T47.3 Saline and osmotic laxatives
0.000 0.691 0.309
T47.2 Stimulant laxatives
0.000 0.691 0.309
T47.0 Histamine H(2)-receptor antagonists
0.000 0.691 0.309
T41.5 Therapeutic gases
0.000 0.691 0.309
T41.4 Anaesthetic, unspecified
0.000 0.691 0.309
T41.3 Local anaesthetics
0.000 0.691 0.309
T41.2 Other and unspecified general anaesthetics
0.000 0.691 0.309
T41.1 Intravenous anaesthetics
0.000 0.691 0.309
T41.0 Inhaled anaesthetics
0.000 0.691 0.309
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.691 0.309
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.691 0.309
T48.5 Anti-common-cold drugs
0.000 0.691 0.309
T48.4 Expectorants
0.000 0.691 0.309
T48.3 Antitussives
0.000 0.691 0.309
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.691 0.309
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.691 0.309
T48.0 Oxytocic drugs
0.000 0.691 0.309
T49.9 Topical agent, unspecified
0.000 0.691 0.309
T49.8 Other topical agents
0.000 0.691 0.309
T49.7 Dental drugs, topically applied
0.000 0.691 0.309
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.691 0.309
T49.5 Ophthalmological drugs and preparations
0.000 0.691 0.309
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.691 0.309
T49.3 Emollients, demulcents and protectants
0.000 0.691 0.309
T49.2 Local astringents and local detergents
0.000 0.691 0.309
T49.1 Antipruritics
0.000 0.691 0.309
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.691 0.309
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.702 0.298
T37.5 Antiviral drugs
0.000 0.702 0.298
T37.4 Anthelminthics
0.000 0.702 0.298
T37.3 Other antiprotozoal drugs
0.000 0.702 0.298
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.702 0.298
T37.1 Antimycobacterial drugs
0.000 0.702 0.298
T37.0 Sulphonamides
0.000 0.702 0.298
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.292 0.708 0.000
C67.0 Trigone of bladder
0.291 0.709 0.000
C67.3 Anterior wall of bladder
0.289 0.711 0.000
T38.1 Thyroid hormones and substitutes
0.000 0.712 0.288
T38.9 Other and unspecified hormone antagonists
0.000 0.713 0.287
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.713 0.287
T38.7 Androgens and anabolic congeners
0.000 0.713 0.287
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.713 0.287
T38.5 Other oestrogens and progestogens
0.000 0.713 0.287
T38.4 Oral contraceptives
0.000 0.713 0.287
T38.2 Antithyroid drugs
0.000 0.713 0.287
T38.0 Glucocorticoids and synthetic analogues
0.000 0.713 0.287
C67.1 Dome of bladder
0.286 0.714 0.000
T45.0 Antiallergic and antiemetic drugs
0.000 0.715 0.285
C66 Malignant neoplasm of ureter
0.284 0.716 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.717 0.282
T45.8 Other primarily systemic and haematological agents
0.000 0.717 0.282
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.717 0.282
T45.6 Fibrinolysis-affecting drugs
0.000 0.717 0.282
T45.4 Iron and its compounds
0.000 0.717 0.282
T45.3 Enzymes, not elsewhere classified
0.000 0.717 0.282
T45.2 Vitamins, not elsewhere classified
0.000 0.717 0.282
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.718 0.282
C15-C26 Malignant neoplasms of digestive organs
0.276 0.724 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.726 0.274
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.726 0.274
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.726 0.274
T46.7 Peripheral vasodilators
0.000 0.726 0.274
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.726 0.274
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.726 0.274
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.266 0.734 0.000
T39.0 Salicylates
0.000 0.734 0.265
C37 Malignant neoplasm of thymus
0.265 0.735 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.735 0.265
T36.8 Other systemic antibiotics
0.000 0.735 0.265
T36.7 Antifungal antibiotics, systemically used
0.000 0.735 0.265
T36.6 Rifamycins
0.000 0.735 0.265
T36.5 Aminoglycosides
0.000 0.735 0.265
T36.4 Tetracyclines
0.000 0.735 0.265
T36.3 Macrolides
0.000 0.735 0.265
T36.2 Chloramphenicol group
0.000 0.735 0.265
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.735 0.265
C21 Malignant neoplasm of anus and anal canal
0.261 0.739 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.260 0.739 0.001
C97 Malignant neoplasms of independent (primary) multiple sites
0.257 0.743 0.000
C34.8 Overlapping lesion of bronchus and lung
0.256 0.744 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.744 0.256
T50.8 Diagnostic agents
0.000 0.746 0.254
T50.7 Analeptics and opioid receptor antagonists
0.000 0.746 0.254
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.746 0.254
T50.5 Appetite depressants
0.000 0.746 0.254
T50.4 Drugs affecting uric acid metabolism
0.000 0.746 0.254
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.746 0.254
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.746 0.254
T50.1 Loop [high-ceiling] diuretics
0.000 0.746 0.254
T50.0 Mineralocorticoids and their antagonists
0.000 0.746 0.254
C26 Malignant neoplasm of other and ill-defined digestive organs
0.251 0.749 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.750 0.249
C40-C41 Malignant neoplasms of bone and articular cartilage
0.249 0.751 0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.248 0.752 0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
0.247 0.753 0.000
C31 Malignant neoplasm of accessory sinuses
0.247 0.753 0.000
C33 Malignant neoplasm of trachea
0.247 0.753 0.000
C67.5 Bladder neck
0.246 0.754 0.000
C67.7 Urachus
0.245 0.754 0.000
C21.0 Anus, unspecified
0.244 0.756 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.756 0.244
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.244 0.756 0.000
C68 Malignant neoplasm of other and unspecified urinary organs
0.241 0.758 0.000
C30 Malignant neoplasm of nasal cavity and middle ear
0.240 0.760 0.000
C34.1 Upper lobe, bronchus or lung
0.240 0.760 0.000
C38 Malignant neoplasm of heart, mediastinum and pleura
0.240 0.760 0.000
C80.0 Malignant neoplasm, primary site unknown, so stated
0.238 0.762 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.237 0.763 0.000
C22.9 Liver, unspecified
0.234 0.766 0.000
C67.2 Lateral wall of bladder
0.233 0.767 0.000
C26.0 Intestinal tract, part unspecified
0.231 0.769 0.000
C17 Malignant neoplasm of small intestine
0.223 0.777 0.000
C67.8 Overlapping lesion of bladder
0.221 0.779 0.000
C80.9 Malignant neoplasm, unspecified
0.218 0.782 0.000
C70 Malignant neoplasm of meninges
0.217 0.782 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.786 0.214
C69 Malignant neoplasm of eye and adnexa
0.207 0.793 0.000
C45 Mesothelioma
0.206 0.794 0.000
C21.8 Overlapping lesion of rectum, anus and anal canal
0.205 0.795 0.000
C74 Malignant neoplasm of adrenal gland
0.203 0.796 0.000
T36.0 Penicillins
0.000 0.797 0.203
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.202 0.798 0.000
C21.1 Anal canal
0.199 0.801 0.000
C16 Malignant neoplasm of stomach
0.199 0.801 0.000
C25 Malignant neoplasm of pancreas
0.195 0.805 0.000
C65 Malignant neoplasm of renal pelvis
0.192 0.807 0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
0.191 0.809 0.000
C26.9 Ill-defined sites within the digestive system
0.191 0.809 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.001 0.811 0.189
C21.2 Cloacogenic zone
0.187 0.813 0.000
C45.0 Mesothelioma of pleura
0.187 0.813 0.000
C75 Malignant neoplasm of other endocrine glands and related structures
0.187 0.813 0.000
C23 Malignant neoplasm of gallbladder
0.187 0.813 0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
0.184 0.816 0.000
C70.0 Cerebral meninges
0.183 0.817 0.000
C17.9 Small intestine, unspecified
0.181 0.819 0.000
C26.8 Overlapping lesion of digestive system
0.180 0.819 0.000
C26.1 Spleen
0.180 0.819 0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)
0.179 0.821 0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs
0.179 0.821 0.000
C22.7 Other specified carcinomas of liver
0.178 0.822 0.000
C22.4 Other sarcomas of liver
0.178 0.822 0.000
C22.3 Angiosarcoma of liver
0.178 0.822 0.000
C22.2 Hepatoblastoma
0.178 0.822 0.000
C31.9 Accessory sinus, unspecified
0.177 0.823 0.000
C31.8 Overlapping lesion of accessory sinuses
0.177 0.823 0.000
C31.3 Sphenoidal sinus
0.177 0.823 0.000
C31.2 Frontal sinus
0.177 0.823 0.000
C31.1 Ethmoidal sinus
0.177 0.823 0.000
C31.0 Maxillary sinus
0.177 0.823 0.000
C39.9 Ill-defined sites within the respiratory system
0.177 0.823 0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs
0.177 0.823 0.000
C39.0 Upper respiratory tract, part unspecified
0.177 0.823 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.823 0.177
C74.9 Adrenal gland, unspecified
0.175 0.825 0.000
C68.9 Urinary organ, unspecified
0.173 0.827 0.000
C68.8 Overlapping lesion of urinary organs
0.173 0.827 0.000
C68.1 Paraurethral glands
0.173 0.827 0.000
C68.0 Urethra
0.173 0.827 0.000
C30.1 Middle ear
0.172 0.828 0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura
0.172 0.828 0.000
C38.3 Mediastinum, part unspecified
0.172 0.828 0.000
C38.2 Posterior mediastinum
0.172 0.828 0.000
C38.1 Anterior mediastinum
0.172 0.828 0.000
C38.0 Heart
0.172 0.828 0.000
C32 Malignant neoplasm of larynx
0.171 0.829 0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
0.170 0.830 0.000
C46 Kaposi's sarcoma
0.170 0.830 0.000
C22.0 Liver cell carcinoma
0.169 0.831 0.000
C30.0 Nasal cavity
0.165 0.835 0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum
0.165 0.835 0.000
C38.4 Pleura
0.165 0.835 0.000
C69.2 Retina
0.164 0.836 0.000
C17.0 Duodenum
0.162 0.837 0.000
C69.9 Eye, unspecified
0.162 0.838 0.000
C24.1 Ampulla of Vater
0.162 0.838 0.000
C17.1 Jejunum
0.162 0.838 0.000
C17.2 Ileum
0.162 0.838 0.000
C71 Malignant neoplasm of brain
0.161 0.838 0.000
C22.1 Intrahepatic bile duct carcinoma
0.161 0.839 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.160 0.840 0.000
C17.8 Overlapping lesion of small intestine
0.160 0.840 0.000
C17.3 Meckel's diverticulum
0.160 0.840 0.000
C25.4 Endocrine pancreas
0.159 0.841 0.000
C43-C44 Melanoma and other malignant neoplasms of skin
0.159 0.841 0.000
C70.9 Meninges, unspecified
0.156 0.844 0.000
C70.1 Spinal meninges
0.156 0.844 0.000
C16.2 Body of stomach
0.155 0.845 0.000
C24.0 Extrahepatic bile duct
0.153 0.847 0.000
C16.3 Pyloric antrum
0.151 0.849 0.000
C50-C50 Malignant neoplasm of breast
0.149 0.851 0.000
C69.8 Overlapping lesion of eye and adnexa
0.149 0.851 0.000
C69.6 Orbit
0.149 0.851 0.000
C69.5 Lachrymal gland and duct
0.149 0.851 0.000
C69.4 Ciliary body
0.149 0.851 0.000
C69.1 Cornea
0.149 0.851 0.000
C69.0 Conjunctiva
0.149 0.851 0.000
C45.2 Mesothelioma of pericardium
0.148 0.852 0.000
C45.1 Mesothelioma of peritoneum
0.148 0.852 0.000
C16.9 Stomach, unspecified
0.146 0.853 0.000
C74.1 Medulla of adrenal gland
0.146 0.854 0.000
C74.0 Cortex of adrenal gland
0.146 0.854 0.000
C41.9 Bone and articular cartilage, unspecified
0.146 0.854 0.000
C25.3 Pancreatic duct
0.145 0.855 0.000
C51-C58 Malignant neoplasms of female genital organs
0.145 0.855 0.000
C24.8 Overlapping lesion of biliary tract
0.145 0.855 0.000
C75.1 Pituitary gland
0.145 0.855 0.000
C45.9 Mesothelioma, unspecified
0.144 0.856 0.000
C25.0 Head of pancreas
0.144 0.856 0.000
C16.6 Greater curvature of stomach, unspecified
0.144 0.856 0.000
C16.8 Overlapping lesion of stomach
0.142 0.857 0.000
C16.4 Pylorus
0.142 0.857 0.000
C45.7 Mesothelioma of other sites
0.142 0.857 0.000
C32.1 Supraglottis
0.141 0.858 0.000
C16.1 Fundus of stomach
0.141 0.859 0.000
C71.8 Overlapping lesion of brain
0.140 0.859 0.000
C25.8 Overlapping lesion of pancreas
0.140 0.860 0.000
C25.7 Other parts of pancreas
0.140 0.860 0.000
C72.9 Central nervous system, unspecified
0.137 0.863 0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system
0.137 0.863 0.000
C72.5 Other and unspecified cranial nerves
0.137 0.863 0.000
C72.4 Acoustic nerve
0.137 0.863 0.000
C72.3 Optic nerve
0.137 0.863 0.000
C72.2 Olfactory nerve
0.137 0.863 0.000
C72.1 Cauda equina
0.137 0.863 0.000
C72.0 Spinal cord
0.137 0.863 0.000
C75.9 Endocrine gland, unspecified
0.137 0.863 0.000
C75.8 Pluriglandular involvement, unspecified
0.134 0.866 0.000
C75.5 Aortic body and other paraganglia
0.134 0.866 0.000
C75.4 Carotid body
0.134 0.866 0.000
C75.3 Pineal gland
0.134 0.866 0.000
C75.2 Craniopharyngeal duct
0.134 0.866 0.000
C75.0 Parathyroid gland
0.134 0.866 0.000
C16.0 Cardia
0.134 0.866 0.000
C25.1 Body of pancreas
0.134 0.866 0.000
C25.9 Pancreas, unspecified
0.134 0.866 0.000
C69.3 Choroid
0.133 0.867 0.000
C41.8 Overlapping lesion of bone and articular cartilage
0.132 0.868 0.000
C41.4 Pelvic bones, sacrum and coccyx
0.132 0.868 0.000
C41.3 Ribs, sternum and clavicle
0.132 0.868 0.000
C41.2 Vertebral column
0.132 0.868 0.000
C41.0 Bones of skull and face
0.131 0.869 0.000
C48.2 Peritoneum, unspecified
0.130 0.870 0.000
C42.4 hematopoietic and reticuloendothelial systems: Hematopoietic system, NOS (ICD-O-3 specific)
0.128 0.872 0.000
C42.3 hematopoietic and reticuloendothelial systems: Reticuloendothelial system, NOS (ICD-O-3 specific)
0.128 0.872 0.000
C42.2 hematopoietic and reticuloendothelial systems: spleen (ICD-O-3 specific)
0.128 0.872 0.000
C42.1 hematopoietic and reticuloendothelial systems: bone marrow (ICD-O-3 specific)
0.128 0.872 0.000
C42.0 hematopoietic and reticuloendothelial systems: blood (ICD-O-3 specific)
0.128 0.872 0.000
C40.9 Bone and articular cartilage of limb, unspecified
0.128 0.872 0.000
C40.8 Overlapping lesion of bone and articular cartilage of limbs
0.128 0.872 0.000
C40.3 Short bones of lower limb
0.128 0.872 0.000
C40.1 Short bones of upper limb
0.128 0.872 0.000
C40.0 Scapula and long bones of upper limb
0.128 0.872 0.000
C40.2 Long bones of lower limb
0.128 0.872 0.000
C10 Malignant neoplasm of oropharynx
0.128 0.872 0.000
C09 Malignant neoplasm of tonsil
0.128 0.872 0.000
C03 Malignant neoplasm of gum
0.126 0.873 0.000
C71.0 Cerebrum, except lobes and ventricles
0.127 0.873 0.000
C00 Malignant neoplasm of lip
0.123 0.877 0.000
C32.8 Overlapping lesion of larynx
0.123 0.877 0.000
C32.3 Laryngeal cartilage
0.123 0.877 0.000
C32.2 Subglottis
0.123 0.877 0.000
C46.9 Kaposi's sarcoma, unspecified
0.122 0.878 0.000
C46.8 Kaposi's sarcoma of multiple organs
0.122 0.878 0.000
C46.7 Kaposi's sarcoma of other sites
0.122 0.878 0.000
C46.3 Kaposi's sarcoma of lymph nodes
0.122 0.878 0.000
C46.2 Kaposi's sarcoma of palate
0.122 0.878 0.000
C46.1 Kaposi's sarcoma of soft tissue
0.122 0.878 0.000
C46.0 Kaposi's sarcoma of skin
0.122 0.878 0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified
0.122 0.878 0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system
0.122 0.878 0.000
C47.6 Peripheral nerves of trunk, unspecified
0.122 0.878 0.000
C47.5 Peripheral nerves of pelvis
0.122 0.878 0.000
C47.4 Peripheral nerves of abdomen
0.122 0.878 0.000
C47.3 Peripheral nerves of thorax
0.122 0.878 0.000
C47.2 Peripheral nerves of lower limb, including hip
0.122 0.878 0.000
C47.1 Peripheral nerves of upper limb, including shoulder
0.122 0.878 0.000
C47.0 Peripheral nerves of head, face and neck
0.122 0.878 0.000
C11 Malignant neoplasm of nasopharynx
0.122 0.878 0.000
C71.2 Temporal lobe
0.122 0.878 0.000
C41.1 Mandible
0.121 0.879 0.000
C16.5 Lesser curvature of stomach, unspecified
0.121 0.879 0.000
C43 Malignant melanoma of skin
0.120 0.880 0.000
C05 Malignant neoplasm of palate
0.119 0.881 0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum
0.119 0.881 0.000
C51 Malignant neoplasm of vulva
0.118 0.882 0.000
C71.7 Brain stem
0.116 0.884 0.000
C71.6 Cerebellum
0.116 0.884 0.000
C71.5 Cerebral ventricle
0.116 0.884 0.000
C57 Malignant neoplasm of other and unspecified female genital organs
0.115 0.885 0.000
C13 Malignant neoplasm of hypopharynx
0.115 0.885 0.000
C08 Malignant neoplasm of other and unspecified major salivary glands
0.115 0.885 0.000
C48.1 Specified parts of peritoneum
0.114 0.885 0.000
C67.9 Bladder, unspecified
0.114 0.886 0.000
C12 Malignant neoplasm of pyriform sinus
0.113 0.887 0.000
C25.2 Tail of pancreas
0.113 0.887 0.000
C04 Malignant neoplasm of floor of mouth
0.112 0.888 0.000
C06 Malignant neoplasm of other and unspecified parts of mouth
0.112 0.888 0.000
C24.9 Biliary tract, unspecified
0.112 0.888 0.000
C55 Malignant neoplasm of uterus, part unspecified
0.111 0.889 0.000
C43.6 Malignant melanoma of upper limb, including shoulder
0.111 0.889 0.000
C18 Malignant neoplasm of colon
0.110 0.890 0.000
C71.3 Parietal lobe
0.108 0.892 0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
0.107 0.893 0.000
C71.4 Occipital lobe
0.107 0.893 0.000
C10.9 Oropharynx, unspecified
0.105 0.895 0.000
C09.9 Tonsil, unspecified
0.105 0.895 0.000
C58 Malignant neoplasm of placenta
0.104 0.896 0.000
J45.9 Asthma, unspecified
0.104 0.896 0.000
C43.5 Malignant melanoma of trunk
0.103 0.897 0.000
C03.0 Upper gum
0.103 0.897 0.000
C48.0 Retroperitoneum
0.102 0.898 0.000
C73 Malignant neoplasm of thyroid gland
0.100 0.900 0.000
J45 Asthma
0.099 0.901 0.000
C51.9 Vulva, unspecified
0.099 0.901 0.000
J44 Other chronic obstructive pulmonary disease
0.099 0.901 0.000
C60-C63 Malignant neoplasms of male genital organs
0.099 0.901 0.000
C18.0 Caecum
0.098 0.902 0.000
C18.3 Hepatic flexure
0.098 0.902 0.000
J40-J47 Chronic lower respiratory diseases
0.098 0.902 0.000
C43.2 Malignant melanoma of ear and external auricular canal
0.098 0.902 0.000
J46 Status asthmaticus
0.097 0.903 0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.097 0.903 0.000
C00.0 External upper lip
0.096 0.903 0.000
C57.9 Female genital organ, unspecified
0.095 0.905 0.000
C11.9 Nasopharynx, unspecified
0.095 0.905 0.000
J44.9 Chronic obstructive pulmonary disease, unspecified
0.095 0.905 0.000
C52 Malignant neoplasm of vagina
0.094 0.906 0.000
F32.9 Depressive episode, unspecified
0.000 0.907 0.093
C05.0 Hard palate
0.093 0.907 0.000
C10.8 Overlapping lesion of oropharynx
0.092 0.908 0.000
C10.4 Branchial cleft
0.092 0.908 0.000
C10.3 Posterior wall of oropharynx
0.092 0.908 0.000
C10.2 Lateral wall of oropharynx
0.092 0.908 0.000
C10.1 Anterior surface of epiglottis
0.092 0.908 0.000
C10.0 Vallecula
0.092 0.908 0.000
C09.8 Overlapping lesion of tonsil
0.092 0.908 0.000
C09.1 Tonsillar pillar (anterior) (posterior)
0.092 0.908 0.000
C09.0 Tonsillar fossa
0.092 0.908 0.000
C03.9 Gum, unspecified
0.091 0.909 0.000
C03.1 Lower gum
0.091 0.909 0.000
C43.1 Malignant melanoma of eyelid, including canthus
0.091 0.909 0.000
C49 Malignant neoplasm of other connective and soft tissue
0.089 0.911 0.000
C00.9 Lip, unspecified
0.088 0.911 0.000
C00.8 Overlapping lesion of lip
0.088 0.911 0.000
C00.6 Commissure of lip
0.088 0.911 0.000
C00.5 Lip, unspecified, inner aspect
0.088 0.911 0.000
C00.4 Lower lip, inner aspect
0.088 0.911 0.000
C00.3 Upper lip, inner aspect
0.088 0.911 0.000
C00.2 External lip, unspecified
0.088 0.911 0.000
C00.1 External lower lip
0.088 0.911 0.000
C11.8 Overlapping lesion of nasopharynx
0.088 0.912 0.000
C11.3 Anterior wall of nasopharynx
0.088 0.912 0.000
C11.2 Lateral wall of nasopharynx
0.088 0.912 0.000
C11.1 Posterior wall of nasopharynx
0.088 0.912 0.000
C11.0 Superior wall of nasopharynx
0.088 0.912 0.000
C19 Malignant neoplasm of rectosigmoid junction
0.087 0.912 0.000
C43.8 Overlapping malignant melanoma of skin
0.086 0.913 0.000
C43.0 Malignant melanoma of lip
0.086 0.913 0.000
C05.8 Overlapping lesion of palate
0.085 0.914 0.000
C05.2 Uvula
0.085 0.914 0.000
C05.1 Soft palate
0.085 0.915 0.000
C51.8 Overlapping lesion of vulva
0.085 0.915 0.000
C51.2 Clitoris
0.085 0.915 0.000
C51.1 Labium minus
0.085 0.915 0.000
C51.0 Labium majus
0.085 0.915 0.000
C18.8 Overlapping lesion of colon
0.084 0.916 0.000
C43.4 Malignant melanoma of scalp and neck
0.084 0.916 0.000
C15 Malignant neoplasm of oesophagus
0.084 0.916 0.000
C07 Malignant neoplasm of parotid gland
0.083 0.917 0.001
C18.2 Ascending colon
0.083 0.917 0.000
C57.8 Overlapping lesion of female genital organs
0.083 0.917 0.000
C57.7 Other specified female genital organs
0.083 0.917 0.000
C57.4 Uterine adnexa, unspecified
0.083 0.917 0.000
C57.3 Parametrium
0.083 0.917 0.000
C57.2 Round ligament
0.083 0.917 0.000
C57.1 Broad ligament
0.083 0.917 0.000
C08.9 Major salivary gland, unspecified
0.082 0.917 0.000
C08.8 Overlapping lesion of major salivary glands
0.082 0.917 0.000
C08.1 Sublingual gland
0.082 0.917 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.